Research and Development

Showing 15 posts of 9599 posts found.

ICON promotes Tom O’Leary

February 9, 2010 Research and Development ICON, appointment, research and development

Tom O’Leary has been appointed president of ICON Central Laboratories, succeeding Bob Scott-Edwards. Scott-Edwards had held the role since August …

Pfizer to personalise brain tumour vaccine

February 8, 2010 Research and Development Pfizer, Qiagen, brain tumour, gliobastoma, vaccines

Pfizer is working with Dutch company Qiagen to develop a companion diagnostic kit for its immunotherapy vaccine for gliobastoma multiforme. …
Blog footer

Digital Pharma: UCB’s online epilepsy community

February 8, 2010 Medical Communications, Research and Development PatientsLikeMe, UCB, community, digital pharma, digital pharma research, patient information

UCB has launched an online community for US epilepsy patients to record ‘real-world’ experiences of the condition. In addition to …

GSK looks to rare diseases research

February 5, 2010 Research and Development GlaxoSmithKline, Orphan

GlaxoSmithKline has launched a new specialist unit to research and develop medicines for rare diseases. The company has identified 5,500 …
ABPI

Barker praises OLS model

February 5, 2010 Research and Development, Sales and Marketing ABPI, Blueprint, OLS

The ABPI’s director general spoke to Pharmafocus about the promise of the new Blueprint at its launch in London last …
Andrew Witty

GSK confirms job cuts but avoids specifics

February 5, 2010 Research and Development, Sales and Marketing 2009 financials, GlaxoSmithKline

GlaxoSmithKline has sidestepped questions about the internal fall-out from its new plan to slash R&D infrastructure costs. Presenting the company’s …
Photo_Miguel_Forte300dpi

Miguel Forte joins TxCell

February 5, 2010 Research and Development TxCell, appointment, research and development

French biotech TxCell has appointed Miguel Forte to fill its newly-created role of chief medical officer. Miguel joins the company …

GSK acquires respiratory candidate

February 4, 2010 Research and Development Apeiron, GlaxoSmithKline, respiratory

GlaxoSmithKline has acquired exclusive rights to a biotherapeutic enzyme developed for use against Acute Respiratory Distress Syndrome (ARDS). The move …

Lancet retracts MMR research conclusions

February 3, 2010 Research and Development MMR, Sanofi, vaccines

The Lancet, the journal which originally published the controversial research linking the MMR vaccine to autism has issued a full …

Digital Pharma: New EMA website previewed

February 3, 2010 Research and Development, Sales and Marketing EMA, branding, digital pharma

The European Medicines Agency is preparing to overhaul its website to make it easier for users to get information. This …

FDA to assess Neupogen biosimilar

February 3, 2010 Research and Development, Sales and Marketing Hospira, Teva, biosimilars

US regulator the FDA has agreed to assess Teva’s application for a biosimilar version of Amgen’s Neupogen (filgrastim). XM02, a …

Parexel sees signs of recovery in Q2 figures

February 2, 2010 Research and Development CRO, Parexel

Contract research organisation Parexel International’s second-quarter net profit fell 34% to $3.5 million on restructuring and investment-impairment charges, but still …

Job cuts at GlaxoSmithKline and AstraZeneca

February 2, 2010 Research and Development, Sales and Marketing AstraZeneca, GlaxoSmithKline

Britain’s two biggest pharma companies GlaxoSmithKline and AstraZeneca are poised to make deep job cuts as business models continue to …
Lilly laboratory

Lilly signs diabetes deal with Alizé Pharma

February 2, 2010 Research and Development Alize, diabetes, lilly, type II

Lilly has signed a new research and licensing deal with Lyon-based Alizé Pharma to develop Alizé’s AZP-01 programme, focused on …

Contract research news in brief

February 2, 2010 Research and Development CRO, PRA, Quintiles

Our round-up of contract research news includes alliances for Quintiles and PRA International, a new CRO serving the Eastern European …
The Gateway to Local Adoption Series

Latest content